Department of Biochemistry & Molecular Biophysics, Washington University School of Medicine, St. Louis, USA ...

The approach is to develop small-molecule drugs that can correct RNA mis-splicing, leading to loss of RNA expression by exon-skipping. It is another way to go after hard-to-target disease ...

GSK took center stage last month, forming standout partnerships and alliances across multiple therapeutic areas.

Biogen meanwhile is also pursuing other avenues of RNA drug discovery and development, and in 2018 expanded the partnership with Ionis Pharma which delivered Spinraza to the market, paying $350 ...

RNA in cells performs an astounding number of functions. Messenger RNA carries the sequences of active genes to the cellular machinery, which turns... | Cell And Molecular Biology ...

Quantum computing and biotech companies are testing whether next-generation computing technology could help them develop ...

New genetic drug delivery platform evades the liver allowing injected genetic material to reach target organs.

GEN uncovers seven biopharma-related trends based on interviews with experts and other industry stakeholders, as well as ...

Veritas In Silico Inc. (JP:130A) has released an update. Veritas In Silico Inc. is expanding its global reach by securing a ...

Further proof of great versatility of Altamira’s platform for extrahepatic RNA deliveryCircular mRNA significantly increasing ...

A new test can differentiate between various types of asthma via a nasal swab. Researchers hope it can eventually help match ...

A new study conducted at the Scojen Institute for Synthetic Biology at Reichman University's Dina Recanati School of Medicine ...